Atrium Therapeutics, Inc.
NASDAQRNA cost to borrow jumped 210% over the past week to 1.85%, up from 0.60% on April 15th, while short interest climbed 346% over the past…
Short interest % of float, cost to borrow, utilization, and put/call ratio for RNA are part of the ORTEX premium tier. Sign up to read the live numbers alongside the analysis.
Snapshot as of 7 May 2026
No long-form analysis yet for RNA. Pulse alerts and the live data picture are available on ORTEX.
Open RNA on ORTEX →Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for RNA — free to start on ORTEX.
Sign up for free →Open RNA on ORTEX